These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35959787)

  • 21. Sarcopenia: An important prognostic factor for males treated for a locally advanced esophageal carcinoma.
    Benadon B; Servagi-Vernat S; Quero L; Cattan P; Guillerm S; Hennequin V; Aparicio T; Lourenço N; Bouché O; Hennequin C
    Dig Liver Dis; 2020 Sep; 52(9):1047-1052. PubMed ID: 32493629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying sarcopenia in advanced non-small cell lung cancer patients using skeletal muscle CT radiomics and machine learning.
    Dong X; Dan X; Yawen A; Haibo X; Huan L; Mengqi T; Linglong C; Zhao R
    Thorac Cancer; 2020 Sep; 11(9):2650-2659. PubMed ID: 32767522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer.
    Huang CY; Sun FJ; Lee J
    Nutrition; 2020 Apr; 72():110642. PubMed ID: 31986319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
    Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
    Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of
    Kim E; Wu HG; Keam B; Kim TM; Kim DW; Paeng JC; Kim HJ; Chang JH
    Clin Lung Cancer; 2019 Jan; 20(1):e9-e23. PubMed ID: 30266585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of the
    Goksel S; Cengiz A; Ozturk H; Yurekli Y
    J Cancer Res Ther; 2021; 17(4):925-930. PubMed ID: 34528543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sarcopenia as a Predictive Factor for Carboplatin Toxicity in Patients with Advanced Non-Small Cell Lung Cancer.
    Turcott JG; Miyagui SM; Gutiérrez Torres S; Cárdenas-Fernández D; Caballé-Perez E; Rios-Garcia E; Cardona AF; Rolfo C; Arrieta O
    Nutr Cancer; 2024; 76(10):985-993. PubMed ID: 39066469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of preoperative evaluation of skeletal muscle index and immune-nutritional status for patients with early-stage non-small cell lung cancer.
    Sato S; Sato M; Shinohara H
    Gen Thorac Cardiovasc Surg; 2023 Jun; 71(6):354-362. PubMed ID: 36562876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma.
    Taguchi S; Akamatsu N; Nakagawa T; Gonoi W; Kanatani A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Homma Y
    Clin Genitourin Cancer; 2016 Jun; 14(3):237-43. PubMed ID: 26337653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive Sarcopenia in Patients With Colorectal Cancer Predicts Survival.
    Deng CY; Lin YC; Wu JS; Cheung YC; Fan CW; Yeh KY; McMahon CJ
    AJR Am J Roentgenol; 2018 Mar; 210(3):526-532. PubMed ID: 29364725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classification based on skeletal muscle mass and the severity of lung emphysema impacts on clinical outcomes after anatomical resection for lung cancer.
    Tsubokawa N; Mimura T; Tadokoro K; Yamashita Y
    Jpn J Clin Oncol; 2022 Aug; 52(8):917-924. PubMed ID: 35438159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
    Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
    BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
    Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcopenia is related to poor prognosis in patients after trimodality therapy for locally advanced non-small cell lung cancer.
    Katsui K; Ogata T; Watanabe K; Yoshio K; Kuroda M; Yamane M; Hiraki T; Kiura K; Toyooka S; Kanazawa S
    Int J Clin Oncol; 2021 Aug; 26(8):1450-1460. PubMed ID: 33880655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphometric parameters of muscle and bone in critically ill patients : Post hoc analysis of the VITdAL-ICU trial.
    Malle O; Maurer D; Wagner D; Schnedl C; Amrein S; Pieber T; Fahrleitner-Pammer A; Dimai HP; Amrein K
    Wien Klin Wochenschr; 2021 Jun; 133(11-12):529-535. PubMed ID: 32945947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low truncal muscle area on chest computed tomography: a poor prognostic factor for the cure of early-stage non-small-cell lung cancer†.
    Sun C; Anraku M; Karasaki T; Kuwano H; Nagayama K; Nitadori JI; Sato M; Nakajima J
    Eur J Cardiothorac Surg; 2019 Mar; 55(3):414-420. PubMed ID: 30289481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low paravertebral muscle mass in patients with bone metastases from lung cancer is associated with poor prognosis.
    Dohzono S; Sasaoka R; Takamatsu K; Hoshino M; Nakamura H
    Support Care Cancer; 2020 Jan; 28(1):389-394. PubMed ID: 31055666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer.
    Khristenko E; Sinitsyn V; Rieden T; Girod P; Kauczor HU; Mayer P; Klauss M; Lyadov V
    PLoS One; 2024; 19(1):e0291185. PubMed ID: 38271373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.
    Salavati A; Duan F; Snyder BS; Wei B; Houshmand S; Khiewvan B; Opanowski A; Simone CB; Siegel BA; Machtay M; Alavi A
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1969-1983. PubMed ID: 28689281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes.
    Nakamura R; Inage Y; Tobita R; Yoneyama S; Numata T; Ota K; Yanai H; Endo T; Inadome Y; Sakashita S; Satoh H; Yuzawa K; Terashima T
    J Thorac Oncol; 2018 Jul; 13(7):895-903. PubMed ID: 29751134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.